92 related articles for article (PubMed ID: 1704855)
1. Induction of morphological change by tyrosine kinase inhibitors in Rous sarcoma virus-transformed rat kidney cells.
Umezawa K; Tanaka K; Hori T; Abe S; Sekizawa R; Imoto M
FEBS Lett; 1991 Feb; 279(1):132-6. PubMed ID: 1704855
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of Abelson oncogene function by erbstatin analogues.
Kawada M; Tawara J; Tsuji T; Honma Y; Hozumi M; Wang JY; Umezawa K
Drugs Exp Clin Res; 1993; 19(6):235-41. PubMed ID: 8013266
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of epidermal growth factor receptor functions by tyrosine kinase inhibitors in NIH3T3 cells.
Umezawa K; Sugata D; Yamashita K; Johtoh N; Shibuya M
FEBS Lett; 1992 Dec; 314(3):289-92. PubMed ID: 1468560
[TBL] [Abstract][Full Text] [Related]
4. Morphological aspects of inhibition of transformation of rat kidney cells infected with a temperature-sensitive mutant of the Rous sarcoma virus by rat fibroblast interferon.
Chen YC; Wu WW; Borchardt KA
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1990 Feb; 23(1):101-5. PubMed ID: 2168311
[TBL] [Abstract][Full Text] [Related]
5. In situ inhibition of tyrosine protein kinase by erbstatin.
Imoto M; Umezawa K; Sawa T; Takeuchi T; Umezawa H
Biochem Int; 1987 Nov; 15(5):989-95. PubMed ID: 3501720
[TBL] [Abstract][Full Text] [Related]
6. F-actin aggregates in transformed cells.
Carley WW; Barak LS; Webb WW
J Cell Biol; 1981 Sep; 90(3):797-802. PubMed ID: 6270163
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of epidermal growth factor-induced DNA synthesis by tyrosine kinase inhibitors.
Umezawa K; Hori T; Tajima H; Imoto M; Isshiki K; Takeuchi T
FEBS Lett; 1990 Jan; 260(2):198-200. PubMed ID: 2298299
[TBL] [Abstract][Full Text] [Related]
8. Phenotypic change from transformed to normal induced by benzoquinonoid ansamycins accompanies inactivation of p60src in rat kidney cells infected with Rous sarcoma virus.
Uehara Y; Hori M; Takeuchi T; Umezawa H
Mol Cell Biol; 1986 Jun; 6(6):2198-206. PubMed ID: 3023921
[TBL] [Abstract][Full Text] [Related]
9. Epiderstatin induces the flat reversion of NRK cells transformed by temperature-sensitive Rous sarcoma virus.
Osada H; Sasaki M; Sonoda T; Isono K
Biosci Biotechnol Biochem; 1992 Nov; 56(11):1801-6. PubMed ID: 1369411
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of fibronectin expression by herbimycin A.
Umezawa K; Atsumi S; Matsushima T; Takeuchi T
Experientia; 1987 Jun; 43(6):614-6. PubMed ID: 3036558
[TBL] [Abstract][Full Text] [Related]
11. Screening of agents which convert 'transformed morphology' of Rous sarcoma virus-infected rat kidney cells to 'normal morphology': identification of an active agent as herbimycin and its inhibition of intracellular src kinase.
Uehara Y; Hori M; Takeuchi T; Umezawa H
Jpn J Cancer Res; 1985 Aug; 76(8):672-5. PubMed ID: 3930444
[TBL] [Abstract][Full Text] [Related]
12. Effect of orthovanadate on commitment of avian myoblasts transformed with Rous sarcoma virus to myogenic differentiation.
Hase H; Isobe A; Kim J
Eur J Cell Biol; 1995 Nov; 68(3):313-22. PubMed ID: 8603684
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylation of tyrosine residues of calmodulin in Rous sarcoma virus-transformed cells.
Fukami Y; Nakamura T; Nakayama A; Kanehisa T
Proc Natl Acad Sci U S A; 1986 Jun; 83(12):4190-3. PubMed ID: 2424020
[TBL] [Abstract][Full Text] [Related]
14. Modulation of fibronectin gene activity in chick embryo fibroblasts transformed by a temperature-sensitive strain (ts68) of Rous sarcoma virus.
Tyagi JS; Hirano H; Pastan I
Nucleic Acids Res; 1985 Nov; 13(22):8275-84. PubMed ID: 2999717
[TBL] [Abstract][Full Text] [Related]
15. Differential tyrosine-specific phosphorylation of integrin in Rous sarcoma virus transformed cells with differing transformed phenotypes.
Horvath AR; Elmore MA; Kellie S
Oncogene; 1990 Sep; 5(9):1349-57. PubMed ID: 1699197
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of serum-induced M-phase progression by a tyrosine kinase inhibitor, erbstatin.
Sugata D; Yamashita K; Umezawa K
Biochem Biophys Res Commun; 1993 Jul; 194(1):239-45. PubMed ID: 8333839
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of CDP-DG:inositol transferase activity in src- and erbB2-transformed cells.
Imoto M; Taniguchi Y; Fujiwara H; Umezawa K
Exp Cell Res; 1994 May; 212(1):151-4. PubMed ID: 7909754
[TBL] [Abstract][Full Text] [Related]
18. The effects of 3-deazaguanine on Rous sarcoma virus transformation.
Chen YC; Liu LA; Borchardt KA
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1990 May; 23(2):197-200. PubMed ID: 2168314
[TBL] [Abstract][Full Text] [Related]
19. Most of the substrates of oncogenic viral tyrosine protein kinases can be phosphorylated by cellular tyrosine protein kinases in normal cells.
Kamps MP; Sefton BM
Oncogene Res; 1988 Sep; 3(2):105-15. PubMed ID: 2465525
[TBL] [Abstract][Full Text] [Related]
20. Vanadate-treated baby hamster kidney fibroblasts show cytoskeleton and adhesion patterns similar to their Rous sarcoma virus-transformed counterparts.
Marchisio PC; D'Urso N; Comoglio PM; Giancotti FG; Tarone G
J Cell Biochem; 1988 Jun; 37(2):151-9. PubMed ID: 2456294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
